Dorsey Brian
- SEC CIK
- 0001380762
Latest role at each company
- SPRY ARS Pharmaceuticals, Inc.Chief Operating Officeras of Jan 5, 2026
Trades
Every Form 4 that lists Dorsey Brian as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| SPRYARS Pharmaceuticals, Inc. | Nov 14, 2025 | Nov 13, 2025 | Dorsey BrianChief Operating Officer | SSaleCommon Stock | −21.83K | $8.71 | −$190.12K | 10.79K | −66.9% | SEC |
| SPRYARS Pharmaceuticals, Inc. | Dec 13, 2024 | Dec 11 – Dec 12, 2024 | Dorsey BrianChief Operating Officer | SSaleCommon Stock | −40K | $12.3488 | −$493.95K | 6.02K | −86.9% | SEC10b5-1 |
| SPRYARS Pharmaceuticals, Inc. | Aug 21, 2024 | Aug 20, 2024 | Dorsey BrianChief Operating Officer | SSaleCommon Stock | −50K | $15.00 | −$750K | 6.02K | −89.2% | SEC10b5-1 |
| SPRYARS Pharmaceuticals, Inc. | Aug 15, 2024 | Aug 13, 2024 | Dorsey BrianChief Operating Officer | SSaleCommon Stock | −30K | $13.00 | −$390K | 6.02K | −83.3% | SEC10b5-1 |